A clinic-grade electrohydraulic platform engineered for the full depth of equine and small animal anatomy — paired with the practice-growth engine that turns therapy into a thriving service line.
Focused extracorporeal shockwave therapy directs high-energy acoustic waves to precise tissue depths, stimulating the body's intrinsic regenerative response — neovascularisation, tissue repair, and durable pain relief. The clinical outcome depends entirely on reaching the target. Most systems cannot.
Stimulates genuine tissue healing in tendon, ligament, and joint pathology — addressing the source rather than managing the symptom.
Delivered standing, without general anaesthesia, incisions, or extended recovery — a low-risk addition to the orthopaedic toolkit.
Deeper equine structures sit beyond the reach of most devices. Undertreatment is a depth problem. This system resolves it.
A high-energy electrohydraulic generator paired with a single integrated applicator that spans the entire equine depth range — no head changes, no compromise on the deepest indications.
Every system is delivered with a field-tested protocol library — the calibration framework that allows the device to be put to clinical use from the first day, across the full range of orthopaedic indications a referral-grade practice encounters.
Every VetRegen practice receives a structured partnership designed to establish the therapy clinically and commercially — the difference between an instrument gathering dust and a thriving, profitable service line.
Comprehensive training so your clinical team delivers every protocol with precision and assurance from day one.
Done-for-you campaigns to announce the therapy to existing clients and attract new cases — immediate demand from the moment you're live.
Ongoing marketing, content, and referral systems that keep new cases coming in month after month — not just at launch.
Pricing guidance, client communication frameworks, and a network of partner practices sharing protocols and outcomes — long-term advisory access.
Flexible BNPL financing turns the device into a monthly commitment covered several times over by treatment revenue — cash-flow positive from the first week of treating.
Circa $930/month over 60 months — priced under the incumbent, and covered by a handful of sessions a week.
3 treatments per week at standard fee schedules more than covers the financing commitment from day one.
The practice keeps the margin. The therapy compounds as referrals build. The device pays for itself.
The incumbent offers a proven modality and then leaves. VetRegen offers a superior device and everything around it — the marketing, the training, and the growth engine that makes the therapy succeed.
| Capability | The Incumbent | VetRegen |
|---|---|---|
| Core technology | Electrohydraulic focused | Electrohydraulic focused Same clinical gold standard |
| Applicator longevity | Refurbished ~$2K each | Longer life, lower COO |
| Patent protection | Patent-protected | Two US patents — newer-gen |
| Price to practice | Circa $50,000 | Circa $45,000 + strong BNPL |
| Modern marketing support | None | Full digital demand-gen programme |
| Practice growth help | None — device delivered, then gone | Complete growth programme, ongoing |
| Sales motion | Distribution-led, minimal direct | Direct, founder-led, proactive |
Book a consultation and we'll walk through the device, the clinical coverage, and the practice-growth model — no obligation, no pressure.
Request a Consultation